Quick Summary
The Income Tax Department has introduced FORM 14 under the Income-tax Act, 2025 to streamline tax incentives for research and development (RD). This new framework replaces earlier provisions and establishes a structured approval mechanism for companies operating in-house RD facilities. The Departme
Daily Limit Reached
You have reached your daily limit of 2 Free News
Subscribe to CCI PRO for unlimited access
Why Upgrade to CCI PRO?
- No Ads
- WhatsApp Community
- Daily E-Newsletter
- Unlimited News Access
- Profile Visitors
- Link Social Profiles
- Featured Job Posts
- Pro Badge
- Expert GST Guidance
- Unlimited Forum Replies
- Download Content in PDF
BEST VALUE
2 YEAR PLAN
3,499
(Excl. of GST ₹629)
1 YEAR PLAN
1,999
(Excl. of GST ₹359)
3 MONTHS PLAN
999
(Excl of GST ₹179)
View all CCI PRO benfits
Already a PRO member? Login here for an ad-free experience.
FAQ :
Form 14 is an official approval order issued by the Department of Scientific and Industrial Research (DSIR) under Section 45(2) of the Income-tax Act, 2025. It confirms that a company's in-house R&D facility meets the conditions for tax benefits.
Form 14 is issued by the Secretary of the Department of Scientific and Industrial Research (DSIR), who is the prescribed authority under Rule 29 of the Income-tax Rules, 2026.
No, Form 14 is not a filing requirement. It acts as an approval certificate that companies must retain for verification to support their claims for tax deductions.
Form 14 includes details such as the company's name and address, nature of business, objectives of scientific research, R&D facility location, DSIR recognition details, and confirmation of approval.
No, receiving Form 14 does not automatically guarantee a tax deduction. Companies must still meet all statutory conditions for claiming deductions.
Yes, the approval granted by Form 14 may be withdrawn if there is non-compliance with the rules or if the DSIR recognition is withdrawn.
CAclubindia
